Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial.

Trower, Mike; Anderson, Richard A; Ballantyne, Elizabeth; Joffe, Hadine; Kerr, Mary; Pawsey, Steve

Trower, Mike; Anderson, Richard A; Ballantyne, Elizabeth; Joffe, Hadine; Kerr, Mary; Pawsey, Steve.

Afiliación

Trower M; NeRRe Therapeutics Limited, Stevenage, UK.
Anderson RA; MRC Centre for Reproductive Health, Queens Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Ballantyne E; NeRRe Therapeutics Limited, Stevenage, UK.
Joffe H; Connors Center for Women's Health and Gender Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Kerr M; NeRRe Therapeutics Limited, Stevenage, UK.
Pawsey S; NeRRe Therapeutics Limited, Stevenage, UK.

Menopause ; 27(5): 498-505, 2020 05.

Article en En | MEDLINE | ID: mdl-32068688

Asunto(s)

Sofocos; Posmenopausia; Método Doble Ciego; Femenino; Sofocos/tratamiento farmacológico; Humanos; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Posmenopausia / Sofocos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Female / Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google